Top News

Press Release | September 20, 2019
Washington, D.C. – Scott Whitaker, president and CEO of the Advanced Medical Technology Association (AdvaMed), issued the following statement on Senator Rick Scott’s decision to co-sponsor S.692, the Protect Medical Innovation Act, which intends to repeal the medical device excise tax.
Press Release | September 19, 2019
Washington, D.C. – The Advanced Medical Technology Association (AdvaMed) brought chief financial officers and research and development executives to Capitol Hill today to push for full repeal of the medical device excise tax.
Press Release | September 18, 2019
BOSTON, MA – Massachusetts Gov. Charles Baker, CMS Administrator Seema Verma and NBA Hall of Famer Bill Walton are among the world-class speakers taking the plenary stage at The MedTech Conference – the premier annual gathering of the medical technology industry – Sept. 23-25 at the Boston Convention and Exhibition Center.


October 7, 2019 to October 8, 2019
| Washington, DC
Click here for the agenda FDA and industry experts are coming together to review the basics of 510(k) submissions. This unique opportunity will help you better understand the FDA perspective on 510(k... Read More
October 9, 2019 | Washington, DC
Click here to view the agenda During this interactive workshop, FDA and industry experts will lead you through the regulatory and practical guidelines governing when an investigational device... Read More
October 10, 2019 to October 11, 2019
| Washington, DC
Click here to view the agenda Completing the set of interactive submissions workshops, industry and FDA experts will lead you through the strategic considerations and practical steps of filing a... Read More
October 22, 2019 to October 23, 2019
| Arlington, VA
View and download the full agenda here Whether you have recently taken on compliance responsibilities, are about to set up a new compliance structure, are in the midst of revamping your existing... Read More
October 22, 2019 | Minneapolis-Saint Paul Metro Area, MN
This interactive workshop will equip you and your team to assess the value of your technology using Advamed’s Value Framework – especially as it relates to getting coverage and reimbursement. The... Read More

Industry News

NEW YORK, Sept. 18, 2019 /PRNewswire/ -- TEAMFund ("Transforming Equity and Access for MedTech") -- a novel hybrid organization combining a Non-Profit with a For-Profit Fund investing in medical technology companies that improve patient access in low-resource settings -- today announced the Final Closing of its $30mm Inaugural Fund. The Fund is led by longtime MedTech investor, Yousuf Mazhar and Tim Ring, former Chairman and CEO of C.R. Bard. TEAMFund was the inspiration of Ms. Kathryn Gleason...
BOSTON--(BUSINESS WIRE)--ApiFix Ltd., a leading motion-preservation scoliosis correction company, today announced that it has received approval from the U.S. Food and Drug Administration (FDA) via a Humanitarian Device Exemption (HDE) to market the Minimally Invasive Deformity Correction (MID-C) system for the treatment of progressive adolescent idiopathic scoliosis (AIS). AIS is the most common type of scoliosis with no identifiable cause and affects 2%-3% of children between ages 10 to 21....
LOS ANGELES--(BUSINESS WIRE)--MedTech Innovator, the premier nonprofit accelerator in the medical technology industry, today announced the 50 companies selected to participate in the organization’s flagship four-month program, featuring leading-edge device, diagnostic, and digital health technologies from around the world. These best-in-class startups will receive unparalleled visibility and access to leading manufacturers, providers, investors, and other industry stakeholders. “We take great...
Aimed at reducing medication errors and related healthcare costs, Ivenix prepares to bring its infusion system to the $4.7 billion North American infusion market BOSTON, June 11, 2019 – The U.S. Food and Drug Administration (FDA) has issued 510(k) clearance for the Ivenix Infusion System, ushering in a new era of infusion systems designed to make infusions safer, while lowering the total cost of ownership. Ivenix looks to disrupt the $4.7 billion North American infusion market, which has been...
FDA clearance marks key regulatory milestone and advances commercial strategy for launch in U.S. hospital market in 2019 FORT LAUDERDALE, Fla.--(BUSINESS WIRE)-- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company dedicated to improving clinical outcomes and enhancing the cost-efficiency of colonoscopy, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (“FDA”) for the second-generation Pure-Vu® System (“...

Twitter Feed

September 20, 2019 - 4:01pm
Using innovative medical technology, anesthesiologists can use ultrasound guidance to put medication right on top o…
September 20, 2019 - 3:01pm
“I was immobile. I couldn’t do anything.” Read how Skip got moving again with the help of innovative medical techno…